SERCA PHARMACEUTICALS AS
Organization
- CEO
- KH
Kjetil Hestdal1960
- Chairman of the board
- EP
- Years since formation
- 7 years
- since Nov 7, 2018
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 895,550
- 1 share class
- Total number of shareholders
- 16
- 8 companies, 8 persons
Financials
- Total operating income 2024
- 4,714,624
- NOK
- Annual total result 2024
- -1,159,259
- NOK
- Total equity 2024
- 27,645,238
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
KH 1960 | Managing Director/CEO | 1.31 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
EP | Chairman | - |
KS | Board Member | - |
JH | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
| - | 5.43 % indirectly | |
TM 1943 | - | 4.34 % indirectly |
JF | - | 3.28 % indirectly |
| - | 2.49 % indirectly | |
PH 1956 | - | 2.14 % indirectly |
KH 1960 | Managing Director/CEO | 1.31 % indirectly |
KG 1964 | - | 1.31 % indirectly |
| - | 1.16 % indirectly | |
NH 1985 | - | 1.16 % indirectly |
Last update: Jun 7, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 362,247 | 40.45 % | |
| Ordinary shares | 234,032 | 26.13 % | |
| Ordinary shares | 97,632 | 10.9 % | |
| Ordinary shares | 81,438 | 9.09 % | |
| Ordinary shares | 40,000 | 4.47 % | |
| Ordinary shares | 23,385 | 2.61 % | |
| Ordinary shares | 22,260 | 2.49 % | |
KT 1965 | Ordinary shares | 7,070 | 0.79 % |
KS | Ordinary shares | 5,246 | 0.59 % |
TL | Ordinary shares | 4,880 | 0.54 % |
BL 1976 | Ordinary shares | 4,200 | 0.47 % |
EØ 1986 | Ordinary shares | 3,640 | 0.41 % |
AI | Ordinary shares | 3,540 | 0.4 % |
| Ordinary shares | 2,960 | 0.33 % | |
IS 1960 | Ordinary shares | 1,740 | 0.19 % |
JM | Ordinary shares | 1,280 | 0.14 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 4,714,624 | 3,571,688 | 1,984,763 | 2,057,459 |
Annual Total Result | -1,159,259 | -4,423,990 | -2,795,714 | -2,654,458 |
Total assets | 40,622,026 | 17,923,659 | 12,568,622 | 17,275,207 |
Total liabilities | 12,976,788 | 1,532,247 | 1,897,298 | 3,808,169 |
Total equity | 27,645,238 | 16,391,412 | 10,671,324 | 13,467,038 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 4,714,624 | 3,571,688 | 1,984,763 | 2,057,459 |
Total operating costs | 6,241,130 | 7,992,931 | 4,734,155 | 4,720,256 |
Operating result | -1,526,506 | -4,421,243 | -2,749,392 | -2,662,797 |
Financial income/costs | 367,247 | -2,747 | -46,323 | 8,339 |
Profit before tax | -1,159,259 | -4,423,990 | -2,795,714 | -2,654,458 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -1,159,259 | -4,423,990 | -2,795,714 | -2,654,458 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 27,248,235 | 0 | 0 | 0 |
Total current assets | 13,373,791 | 17,923,659 | 12,568,622 | 17,275,207 |
Total assets | 40,622,026 | 17,923,659 | 12,568,622 | 17,275,207 |
Short term debt | 4,362,021 | 1,532,247 | 1,897,298 | 3,808,169 |
Long term debt | 8,614,767 | 0 | 0 | 0 |
Total liabilities | 12,976,788 | 1,532,247 | 1,897,298 | 3,808,169 |
Contributed capital | 20,815,402 | 20,815,402 | 10,671,324 | 13,467,038 |
Retained earnings | 6,829,836 | -4,423,990 | 0 | 0 |
Total equity | 27,645,238 | 16,391,412 | 10,671,324 | 13,467,038 |
Total equity and liabilities | 40,622,026 | 17,923,659 | 12,568,622 | 17,275,207 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises